These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 24418575)

  • 1. MUC1: a novel metabolic master regulator.
    Mehla K; Singh PK
    Biochim Biophys Acta; 2014 Apr; 1845(2):126-35. PubMed ID: 24418575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MUC1 mucin stabilizes and activates hypoxia-inducible factor 1 alpha to regulate metabolism in pancreatic cancer.
    Chaika NV; Gebregiworgis T; Lewallen ME; Purohit V; Radhakrishnan P; Liu X; Zhang B; Mehla K; Brown RB; Caffrey T; Yu F; Johnson KR; Powers R; Hollingsworth MA; Singh PK
    Proc Natl Acad Sci U S A; 2012 Aug; 109(34):13787-92. PubMed ID: 22869720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting MUC1-C inhibits the AKT-S6K1-elF4A pathway regulating TIGAR translation in colorectal cancer.
    Ahmad R; Alam M; Hasegawa M; Uchida Y; Al-Obaid O; Kharbanda S; Kufe D
    Mol Cancer; 2017 Feb; 16(1):33. PubMed ID: 28153010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MUC1: a multifaceted oncoprotein with a key role in cancer progression.
    Nath S; Mukherjee P
    Trends Mol Med; 2014 Jun; 20(6):332-42. PubMed ID: 24667139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MUC1 protein induces urokinase-type plasminogen activator (uPA) by forming a complex with NF-κB p65 transcription factor and binding to the uPA promoter, leading to enhanced invasiveness of cancer cells.
    Mori Y; Akita K; Tanida S; Ishida A; Toda M; Inoue M; Yashiro M; Sawada T; Hirakawa K; Nakada H
    J Biol Chem; 2014 Dec; 289(51):35193-204. PubMed ID: 25371209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MUC1 oncoprotein promotes autophagy in a survival response to glucose deprivation.
    Yin L; Kharbanda S; Kufe D
    Int J Oncol; 2009 Jun; 34(6):1691-9. PubMed ID: 19424588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MUC1 oncoprotein mitigates ER stress via CDA-mediated reprogramming of pyrimidine metabolism.
    Olou AA; King RJ; Yu F; Singh PK
    Oncogene; 2020 Apr; 39(16):3381-3395. PubMed ID: 32103170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokine and progesterone receptor interplay in the regulation of MUC1 gene expression.
    Dharmaraj N; Wang P; Carson DD
    Mol Endocrinol; 2010 Dec; 24(12):2253-66. PubMed ID: 20962044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MUC1-C Represses the Crumbs Complex Polarity Factor CRB3 and Downregulates the Hippo Pathway.
    Alam M; Bouillez A; Tagde A; Ahmad R; Rajabi H; Maeda T; Hiraki M; Suzuki Y; Kufe D
    Mol Cancer Res; 2016 Dec; 14(12):1266-1276. PubMed ID: 27658423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular crosstalk between MUC1 and STAT3 influences the anti-proliferative effect of Napabucasin in epithelial cancers.
    Bose M; Sanders A; Handa A; Vora A; Cardona MR; Brouwer C; Mukherjee P
    Sci Rep; 2024 Feb; 14(1):3178. PubMed ID: 38326371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MUC1-Mediated Metabolic Alterations Regulate Response to Radiotherapy in Pancreatic Cancer.
    Gunda V; Souchek J; Abrego J; Shukla SK; Goode GD; Vernucci E; Dasgupta A; Chaika NV; King RJ; Li S; Wang S; Yu F; Bessho T; Lin C; Singh PK
    Clin Cancer Res; 2017 Oct; 23(19):5881-5891. PubMed ID: 28720669
    [No Abstract]   [Full Text] [Related]  

  • 12. The reactive tumor microenvironment: MUC1 signaling directly reprograms transcription of CTGF.
    Behrens ME; Grandgenett PM; Bailey JM; Singh PK; Yi CH; Yu F; Hollingsworth MA
    Oncogene; 2010 Oct; 29(42):5667-77. PubMed ID: 20697347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MUC1 facilitates metabolomic reprogramming in triple-negative breast cancer.
    Goode G; Gunda V; Chaika NV; Purohit V; Yu F; Singh PK
    PLoS One; 2017; 12(5):e0176820. PubMed ID: 28464016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erb-B2 homodimerization inhibits MUC1 transcription in cultured human mammary epithelial cells.
    Canbay E
    Cell Biol Int; 2003; 27(6):477-81. PubMed ID: 12798775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MUC1 oncoprotein is a druggable target in human prostate cancer cells.
    Joshi MD; Ahmad R; Yin L; Raina D; Rajabi H; Bubley G; Kharbanda S; Kufe D
    Mol Cancer Ther; 2009 Nov; 8(11):3056-65. PubMed ID: 19887552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of the MUC1-C oncoprotein induces multiple myeloma cell death by down-regulating TIGAR expression and depleting NADPH.
    Yin L; Kosugi M; Kufe D
    Blood; 2012 Jan; 119(3):810-6. PubMed ID: 22117045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucin 1 enhances the tumor angiogenic response by activation of the AKT signaling pathway.
    Woo JK; Choi Y; Oh SH; Jeong JH; Choi DH; Seo HS; Kim CW
    Oncogene; 2012 Apr; 31(17):2187-98. PubMed ID: 21927028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MUC1 is an oncoprotein with a significant role in apoptosis (Review).
    Supruniuk K; Radziejewska I
    Int J Oncol; 2021 Sep; 59(3):. PubMed ID: 34278474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A signaling pathway consisting of miR-551b, catalase and MUC1 contributes to acquired apoptosis resistance and chemoresistance.
    Xu X; Wells A; Padilla MT; Kato K; Kim KC; Lin Y
    Carcinogenesis; 2014 Nov; 35(11):2457-66. PubMed ID: 25085901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting the MUC1-C oncoprotein downregulates HER2 activation and abrogates trastuzumab resistance in breast cancer cells.
    Raina D; Uchida Y; Kharbanda A; Rajabi H; Panchamoorthy G; Jin C; Kharbanda S; Scaltriti M; Baselga J; Kufe D
    Oncogene; 2014 Jun; 33(26):3422-31. PubMed ID: 23912457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.